ArchPoint Investors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,020
| Closed | -$226K | – | 57 |
|
|
2022
Q4 | $226K | Buy |
+2,020
| New | +$206K | 0.11% | 51 |
|
|
2021
Q4 | – | Sell |
-7,477
| Closed | -$566K | – | 101 |
|
|
2021
Q3 | $566K | Buy |
+7,477
| New | +$569K | 0.17% | 52 |
|
|
2021
Q2 | – | Sell |
-85,193
| Closed | -$6.32M | – | 84 |
|
|
2021
Q1 | $6.32M | Sell |
85,193
-4,454
| -5% | -$329K | 1.79% | 13 |
|
|
2020
Q4 | $7.05M | Sell |
89,647
-251
| -0.3% | -$19.2K | 1.95% | 10 |
|
|
2020
Q3 | $7.17M | Buy |
89,898
+6,516
| +8% | +$510K | 2.29% | 9 |
|
|
2020
Q2 | $6.2M | Sell |
83,382
-393
| -0.5% | -$29.6K | 1.99% | 10 |
|
|
2020
Q1 | $6.2M | Sell |
83,775
-252
| -0.3% | -$19.8K | 2.44% | 8 |
|
|
2019
Q4 | $7.34M | Sell |
84,027
-22,951
| -21% | -$1.89M | 2.24% | 8 |
|
|
2019
Q3 | $6.83M | Buy |
106,978
+73,132
| +216% | +$5.86M | 2.31% | 8 |
|
|
2019
Q2 | $2.73M | Sell |
33,846
-35,755
| -51% | -$2.74M | 0.86% | 22 |
|
|
2019
Q1 | $5.56M | Hold |
69,601
| – | – | 1.66% | 10 |
|
|
2018
Q4 | $5.11M | Sell |
69,601
-3,668
| -5% | -$259K | 1.77% | 9 |
|
|
2018
Q3 | $4.99M | Buy |
73,269
+3,560
| +5% | +$227K | 1.36% | 15 |
|
|
2018
Q2 | $4.07M | Buy |
69,709
+15,720
| +29% | +$887K | 1.17% | 17 |
|
|
2018
Q1 | $2.83M | Sell |
53,989
-346
| -0.6% | -$18.7K | 0.83% | 27 |
|
|
2017
Q4 | $2.94M | Hold |
54,335
| – | – | 0.92% | 24 |
|
|
2017
Q3 | $3.34M | Sell |
54,335
-786
| -1% | -$47.7K | 1.07% | 22 |
|
|
2017
Q2 | $3.4M | Sell |
55,121
-6,068
| -10% | -$369K | 1.08% | 23 |
|
|
2017
Q1 | $3.72M | Sell |
61,189
-4,024
| -6% | -$244K | 1.4% | 15 |
|
|
2016
Q4 | $3.66M | Hold |
65,213
| – | – | 2.15% | 15 |
|
|
2016
Q3 | $3.88M | Sell |
65,213
-2,992
| -4% | -$175K | 2.22% | 15 |
|
|
2016
Q2 | $3.75M | Sell |
68,205
-1,179
| -2% | -$62.7K | 2.14% | 14 |
|
|
2016
Q1 | $3.5M | Hold |
69,384
| – | – | 1.92% | 14 |
|
|
2015
Q4 | $3.5M | Buy |
69,384
+3,569
| +5% | +$180K | 2.46% | 13 |
|
|
2015
Q3 | $3.1M | Buy |
65,815
+298
| +0.5% | +$15.8K | 2.15% | 12 |
|
|
2015
Q2 | $3.56M | Hold |
65,517
| – | – | 2.22% | 11 |
|
|
2015
Q1 | $3.59M | Hold |
65,517
| – | – | 2.45% | 10 |
|
|
2014
Q4 | $3.55M | Hold |
65,517
| – | – | 2.63% | 9 |
|
|
2014
Q3 | $3.71M | Hold |
65,517
| – | – | 3.14% | 5 |
|
|
2014
Q2 | $3.62M | Sell |
65,517
-251
| -0.4% | -$13.7K | 3.05% | 6 |
|
|
2014
Q1 | $3.56M | Sell |
65,768
-1,965
| -3% | -$102K | 3.21% | 5 |
|
|
2013
Q4 | $3.23M | Sell |
67,733
-3,396
| -5% | -$155K | 2.94% | 8 |
|
|
2013
Q3 | $3.23M | Sell |
71,129
-84
| -0.1% | -$3.83K | 3.56% | 4 |
|
|
2013
Q2 | $3.16M | Buy |
+71,213
| New | +$3.18M | 3.72% | 4 |
|
Other funds holding MRK
ArchPoint Investors's MRK Position: Q1 2023 in Review
ArchPoint Investors sold out of Merck (MRK) in Q1 2023, closing a stake of 2,020 shares — an estimated $226K sold.
ArchPoint Investors first reported a position in MRK in Q2 2013 and held it in 34 quarters. The position peaked at $7.34M in Q4 2019. 3,180 funds tracked by Wall St. Rank hold MRK as of Q1 2023.
- ArchPoint Investors reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
- ArchPoint Investors sold 2,020 Merck shares in Q1 2023, an estimated $226K.
- ArchPoint Investors first reported a position in Merck in Q2 2013 and held it in 34 quarters.
- ArchPoint Investors's Merck position peaked at $7.34M in Q4 2019.
- 3,180 funds tracked by Wall St. Rank held Merck as of Q1 2023.
Based on ArchPoint Investors's 13F filing for Q1 2023, filed 12 May 2023.